Great for getting this thread started juiceer.
But, we already know that the best drug available for LL is Forteo/Forsteo. It stimulates bone growth so much it causes bone cancer in mice, and potentially in humans who undergo a lengthy treatment.
The problem with teriparatide is it's a systematic drug mainly for decreasing the risk of osteoporosis in general. There are pretty much no actual scientific studies done on fracture healing. Along with that, it also comes with its serving of side effects.
IGF-1 is effective when injected locally, meaning there's no need for systematic dosages. Thymosine beta 4 is a healing peptide with no adverse side effects and has been shown in rats to increase the healing of fractures. There's no reason to write off new potential treatments just because there is an approved drug in the market. It's even possible for synergy.
All I know is if I was gonna get a LL surgery, I wouldn't write off potential treatments that aren't yet in the eyes of the public, because recovery is paramount.
HGH supplementation while the growth plates are still open is known to increase adult height, and there are peptides that simulate your body to release large amounts of GH for much cheaper. What would have happened to the potential candidates who were quick to ignore the open clinical trials?